Isopentyl caffeate as a promising drug for the treatment of leishmaniasis: An in silico and in vivo study

Leishmaniasis is recognised as the second largest parasitic disease worldwide and yet a neglected disease. The current pharmacological treatments are associated with significant challenges, including high toxicity, high cost and parasitic resistance. Considering the potential of isopentyl caffeate (...

Cijeli opis

Bibliografski detalji

Glavni autori:	Wanessa S. Mota, Simone S.C. Oliveira, Matheus M. Pereira, Damião P. Souza, Mayara Castro, Pollyanna S. Gomes, Herbert L.M. Guedes, Vinícius F. Souza, André L.S. Santos, Ricardo L.C. Albuquerque-Junior, Juliana C. Cardoso, Cristina Blanco-Llamero, Sona Jain, Eliana B. Souto, Patrícia Severino
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-01-01
Serija:	Current Research in Biotechnology
Teme:	Leishmania Isopentyl caffeate In silico Pharmacokinetics ADME Bioavailability
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2590262824000352
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!